EP Patent

EP4538262A1 — Cocrystals of vorasidenib

Assigned to Sandoz AG · Expires 2025-04-16 · 1y expired

What this patent protects

The present invention relates to vorasidenib solid-state forms, to a pharmaceutical composition comprising them, and to processes for their preparation.

USPTO Abstract

The present invention relates to vorasidenib solid-state forms, to a pharmaceutical composition comprising them, and to processes for their preparation.

Drugs covered by this patent

Voranigo (VORASIDENIB) · Servier

Patent Metadata

Patent number: EP4538262A1
Jurisdiction: EP
Classification: —
Expires: 2025-04-16
Drug substance claim: No
Drug product claim: No
Assignee: Sandoz AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.